People receiving a year of abatacept (Orencia) injections had onset of rheumatoid arthritis postponed by up to four years, ...
Treating people who are at high risk of rheumatoid arthritis (RA) can delay the onset of the disease for several years, with ...
inews.co.uk on MSN
The breakthrough that could stop arthritis and diabetes in their tracks
For a long time, treatments for autoimmune diseases could only quash the symptoms - now new drugs may tackle the underlying ...
Patients who require biologic disease-modifying antirheumatic drugs (DMARDs) for severe RA are less likely to achieve sustained DMARD-free remission than those not needing the medication. Patients ...
Advances in biotechnology, a greater understanding of the immunopathogenesis of rheumatoid arthritis (RA) and a desire for more effective therapeutics have led to the development of a class of ...
Original Medicare covers most medically necessary treatments for rheumatoid arthritis (RA), including biologics like adalimumab (Humira), etanercept (Enbrel), infliximab (Remicade, Inflectra), and ...
SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...
NEW YORK (Reuters Health) - Treating rheumatoid arthritis with "biologic" immunosuppressive drugs, such as TNF-blockers, neither increases nor decreases the risk of heart attack or stroke compared ...
Treatment with biologics does not increase the risk of a second malignancy in rheumatoid arthritis patients who have a history of cancer, according to new research findings presented this week at the ...
Explore the unique aspects of rheumatoid arthritis in men, including diagnosis, symptoms, complications, and support options ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results